GlassScriptPhysician profile
John J Deeney
NPI 1124020680
$1,205.17
in general payments reported to CMS, 2019-2025
18 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $66.97 · 2021: $24.43 · 2022: $224 · 2023: $139 · 2024: $232 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $428.08 | 2019-2023 | Lo Loestrin Fe, Orilissa, Qulipta |
| Astellas Pharma US INC | $250.35 | 2024-2025 | Veozah |
| Therapeuticsmd, INC. | $107.38 | 2019-2022 | |
| Amgen INC. | $67.42 | 2022-2025 | Evenity, Prolia, Prolia |
| Exeltis, USA INC. | $53.93 | 2019-2022 | |
| Daiichi Sankyo INC. | $50.03 | 2019-2024 | Injectafer |
| Merck Sharp & Dohme LLC | $32.67 | 2019-2024 | Gardasil, Gardasil 9 |
| Hologic Sales and Service, LLC | $29.75 | 2019 | |
| Avion Pharmaceuticals | $26.95 | 2019-2020 | |
| Pfizer INC. | $23.51 | 2022 | |
| Covidien LP | $22.50 | 2019 | |
| Millicent US INC | $20.26 | 2025 | Femlyv, Intrarosa |
| Coopersurgical, INC. | $19.38 | 2025 | Paragard T 380a |
| Mylan Pharmaceuticals INC. | $18.75 | 2022 | |
| Glaxosmithkline, LLC. | $16.30 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $13.25 | 2019 | |
| Minerva Surgical, INC | $12.91 | 2019 | |
| Organon LLC | $11.75 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Deeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.